Government Affairs
Refine Search
Pharmaceutical
In London, the Global Pandemic Preparedness Summit is bringing together new sources of funding while aiming to boost cooperation between countries and healthcare organizations in the face of possible future threats. 8 March 2022
Generics
The COVID-19 pandemic has highlighted the critical link between patient access to medicine and a robust medicines manufacturing sector. As health systems begin to recover from the pandemic, a new crisis threatens stability and secure supply of medicines in Europe. 7 March 2022
Pharmaceutical
The European pharma industry has responded to a “non-legislative resolution” detailing plans and actions to move away from using animals in medical research. 7 March 2022
Pharmaceutical
Following the Russian invasion against Ukraine and in solidarity with the people of Ukraine, the European Commission said today it has decided to suspend the cooperation with Russian entities in research, science and innovation. 4 March 2022
Pharmaceutical
Australian patients will have improved access to clinical trials due to reforms to be introduced by the Australian government, following advocacy by pharma trade lobby Medicines Australia and other groups. 4 March 2022
Generics
Generics and biosimilars drug trade group Medicines for Europe has delivered a message to the European Union (EU). 3 March 2022
Pharmaceutical
The US medicines regulator has issued three final guidances to drugmakers regarding cancer clinical trials, reflecting a broader push from the administration to improve healthcare outcomes in oncology. 2 March 2022
Pharmaceutical
Russian drugmaker and global pharma companies will significantly reduce the production of anti-COVID-19 vaccines, however the same plans are not considered in case of other drugs, according to recent statements by representatives of producers and some media, reports The Pharma Letter’s local correspondent. 1 March 2022
Pharmaceutical
Pharmacy Benefit Managers (PBMs) and other middle men have been blamed, particularly by pharmaceutical companies operating in the American market, for the high drug prices in the USA. 25 February 2022
Biotechnology
The long-awaited confirmation from the US Senate of Robert Califf’s nomination to become Food and Drug Administration Commissioner was announced last Tuesday, but on a tight vote. On the research front, Sage Therapeutics and Biogen announced confident results for their depressive disorder candidate zuranolone but questioned were raised on its commercial potential. Regulatory developments included the FDA granting accelerated approval for Agios Pharmaceuticals’ Pyrukynd (mitapivat) for a rare form of anemia. But BioMarin had a setback last Thursday when the FDA said it needed more information to lift the clinical hold on the firm’s gene therapy BMN 307 clinical trial. 20 February 2022
Pharmaceutical
Members of the US House of Representatives have written a letter to Secretary of Health and Human Services (HHS) Xavier Becerra urging him to follow through with the Biden administration’s commitment to lowering exorbitant prescription drug costs. 11 February 2022
Pharmaceutical
Following consultation with members – and heeding the concerns of the Consumers Health Forum (CHF) and patient groups – pharma trade group Medicines Australia reiterates its call to have finalization of the new National Medicines Policy (NMP) delayed until after the federal election. 10 February 2022
Generics
India’s domestic pharmaceutical market is estimated at $42 billion in 2021 and likely to reach $65 billion by 2024 and further expand to reach $120-130 billion by 2030, according to India's Economic Survey. 8 February 2022
Biotechnology
US biotech company Biogen’s troubles over the Alzheimer’s product Aduhelm (aducanumab) show no sign of abating. 7 February 2022
Pharmaceutical
Pharma trade group Medicines Australia is calling for the new National Medicines Policy (NMP) to be pushed back until after the federal election, expected in May. 4 February 2022
Biotechnology
India's national biotech development strategy has called for more engagement with start-ups and seeks to leverage the public-private partnership model to take the industry to $150 billion by 2025. As India prepares to capitalize on the altering nature of global value chains, different states have been made relevant stakeholders with the formation of new investment hotspots, reports The Pharma Letter’s India correspondent. 2 February 2022
Pharmaceutical
Thousands of those most at-risk to COVID-19 will soon be able to access the UK’s second ground-breaking antiviral, the Department of Health and Social Care announced on Friday. 31 January 2022
Pharmaceutical
Trade group Medicines Australia has called for the country’s government to deliver a plan that shortens the time that patients wait for access to the latest innovative treatments and vaccines. 28 January 2022
Biotechnology
The Indian government is looking to amend the New Drugs and Clinical Trial Rules, 2019, act to enable manufacturing of unapproved new drugs while they are still under development. 25 January 2022
Biosimilars
Hailing the benefits of 15 years of biosimilar prescribing in Europe, The Biosimilar Medicines Group has called on the European Medicines Agency to take stronger action to widen access to this type of medicine. 25 January 2022
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Pharmaceutical
Trade group the Association of the British Pharmaceutical Industry (ABPI) has had its say on UK government plans to overhaul the National Health Service (NHS). 21 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze